Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study

Article abstract of DOI:10.1021/acs.jmedchem.5b01194

A series of novel C,N-cyclometalated benzimidazole ruthenium(II) and iridium(III) complexes of the types [(η⁶-p-cymene)RuCl(κ²-N,C-L)] and [(η⁵-C₅Me₅)IrCl(κ²-N,C-L)] (HL = methyl 1-butyl-2-